STERIS plc
No SEC Form 4 filings for $STE in the last 30 days.
STERIS plc plans a $600 million manufacturing, R&D and lab facility in Sanford, North Carolina, at Helix Innovation Park. The project is expected to create 335 jobs and serve as its Chemistries Manufacturing Center of Excellence. North Carolina approved a JDIG grant, potentially reimbursing up to $3.213 million over 12 years, tied to annual performance targets.
North Carolina Railroad Co. and Norfolk Southern are backing a $600 million STERIS Chemistries Manufacturing Center of Excellence in Sanford, N.C. NCRR will spend up to $600,000 on rail infrastructure, enabling at least 160 railcars annually by 2031. The project is expected to create 335+ jobs, with operations starting in 2-3 years, according to company releases.
STERIS plc (STE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001757898 0001757898 2026-07-31 2026-07-31 0001757898 us-gaap:CommonStockMember 2026-07-31 2026-07-31 0001757898 ste:STETwo700SeniorNotesDue2031Member 2026-07-31 2026-07-31 0001757898 ste:Two700SeniorNotesDue2051Member 2026-07-31 2026-07-31 UNITED STATES SECURITIES AND
Over the past 7 days, alphai's AI scored 8 news stories mentioning STE (STERIS plc). Coverage has skewed bullish: 5 bullish, 3 neutral, and 0 bearish.
Recent STE coverage spans financial news, corporate actions and earnings.
The disclosed capex and state support suggest incremental capacity expansion in STERIS’ chemistries manufacturing and distribution network.
The article signals a major US capacity expansion tied to rail-served logistics, which can support medium-term volume growth and supply-chain reliability.
This is a corporate governance update with no direct operational or financial guidance, but it can affect near-term sentiment around board composition.
State-backed expansion and job creation could be a modest positive for near-term sentiment, but it is not a direct earnings or guidance catalyst.
The article discloses a large, state-supported U.S. expansion plan for STERIS, which can support medium-term capacity and capex expectations.
alphai scores every news story that mentions STE with an AI model for sentiment and relevance, and aggregates insider trades from STERIS plc's SEC EDGAR Form 4 filings. Figures refresh continuously.
STERIS plc plans a $600 million manufacturing, R&D and lab facility in Sanford, North Carolina, at Helix Innovation Park. The project is expected to create 335 jobs and serve as its Chemistries Manufacturing Center of Excellence. North Carolina approved a JDIG grant, potentially reimbursing up to $3.213 million over 12 years, tied to annual performance targets.
3 min readNorth Carolina Railroad Co. and Norfolk Southern are backing a $600 million STERIS Chemistries Manufacturing Center of Excellence in Sanford, N.C. NCRR will spend up to $600,000 on rail infrastructure, enabling at least 160 railcars annually by 2031. The project is expected to create 335+ jobs, with operations starting in 2-3 years, according to company releases.
3 min readSTERIS plc (STE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001757898 0001757898 2026-07-31 2026-07-31 0001757898 us-gaap:CommonStockMember 2026-07-31 2026-07-31 0001757898 ste:STETwo700SeniorNotesDue2031Member 2026-07-31 2026-07-31 0001757898 ste:Two700SeniorNotesDue2051Member 2026-07-31 2026-07-31 UNITED STATES SECURITIES AND
2 min readThe article is a political roundup of Democratic governors’ actions in several states. It highlights New Mexico Gov. Michelle Lujan Grisham on housing and ICE protections, New York Gov. Kathy Hochul on a data center moratorium and preschool, and North Carolina Gov. Josh Stein’s announcement that STERIS (NYSE: STE) will invest $600 million and create 335 jobs. It also cites Oregon Gov. Tina Kotek’s $10 million Regional Infrastructure Fund and a tariff impact analysis.
4 min readSTERIS, a health care products and services company, will create 335 jobs in Lee County, North Carolina, and invest $600 million in a new 600,000-square-foot manufacturing and distribution center in Sanford, including R&D and a Center of Excellence for formulated chemistries. The state approved a 12-year JDIG grant, with potential reimbursement up to $3.213 million, and projects $1.8 billion in economic growth.
3 min readSteris (NYSE:STE) reported Q2 CY2026 sales of $1.49 billion, up 7.3% year on year and in line with Wall Street estimates. Non-GAAP adjusted EPS was $2.59, up from $2.34, beating consensus by 3.9%. Adjusted operating margin was 19.1% in Q2. Analysts expect revenue growth of 7.1% and full-year EPS to rise from $10.42 to $11.45.
4 min readSTERIS plc (STE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ste6302026ex991.htm EX-99.1 Document Exhibit 99.1 STERIS Announces Financial Results for Fiscal 2027 First Quarter • Fiscal 2027 first quarter revenue increased 7%; constant currency organic revenue growth was 6% • Fiscal 2027 first quarter as reported diluted EPS incre
6 min readSTERIS plc will invest $600 million to build a 600,000-square-foot Chemistries Manufacturing Center of Excellence in Sanford, North Carolina, creating at least 335 full-time jobs with median salaries of $68,704. The facility will handle manufacturing, R&D, warehousing, and distribution, aiming to be fully staffed by 2030, according to STERIS.
3 min readCarestio Daniel A (President and CEO) sold 4,428 shares of STERIS plc (STE) at an average of $213.82 ($212.00–$214.64, $0.95M total) across 2 trades over 2026-06-04 to 2026-06-05 under a Rule 10b5-1 trading plan.
1 min readBreeden Richard C sold 1,481 shares of STERIS plc (STE) at $209.51 ($0.31M total) on 2026-06-02.
2 min read
